Albert Oriol

Albert Oriol

UNVERIFIED PROFILE

Are you Albert Oriol?   Register this Author

Register author
Albert Oriol

Albert Oriol

Publications by authors named "Albert Oriol"

Are you Albert Oriol?   Register this Author

100Publications

6225Reads

7Profile Views

Limited treatment options in refractory multiple myeloma: promising therapeutic developments.

Expert Rev Anticancer Ther 2020 Jan 3;20(1):31-44. Epub 2020 Jan 3.

Hematology Service and Hemato-Oncology Clinical Trial Unit, Institut Català d'Oncologia, Badalona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2020.1708721DOI Listing
January 2020

A Phase 2 Study of Ibrutinib in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.

Eur J Haematol 2019 Dec 28. Epub 2019 Dec 28.

1st Department of Medicine - Department of Hematology First Faculty of Medicine Charles University and General Hospital in Prague, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13377DOI Listing
December 2019

Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents?

Clin Lymphoma Myeloma Leuk 2019 Sep 5;19(9):585-592.e1. Epub 2019 Jun 5.

Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.05.020DOI Listing
September 2019

Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups.

Clin Lymphoma Myeloma Leuk 2019 Aug 2;19(8):522-530.e1. Epub 2019 May 2.

Department of Clinical Therapeutics, University Athens School of Medicine, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.04.018DOI Listing
August 2019

Second neoplasms in adult patients submitted to haematopoietic stem cell transplantation.

Med Clin (Barc) 2018 06 2;150(11):421-427. Epub 2017 Sep 2.

Servicio de Hematología Clínica, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2017.07.004DOI Listing
June 2018

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials.

J Clin Oncol 2017 Sep 12;35(25):2900-2910. Epub 2017 May 12.

Juan-Jose Lahuerta, Maria-Teresa Cedena, Joaquin Martinez-Lopez, and María-Luisa Martín-Ramos, Hospital 12 de Octubre, CIBERONC; Raquel de Paz, Hospital Universitario La Paz; Rafael Martinez, Hospital Clínico San Carlos; Adrian Alegre, Hospital Universitario La Princesa, Madrid; Bruno Paiva and Jesus F. San-Miguel, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBERONC, Pamplona; Laura Rosiñol, and Joan Blade, Hospital Clínic de Barcelona, Barcelona; Maria-Belen Vidriales, Noemi Puig, Norma C. Gutierrez, Alejandro Martin, and María-Victoria Mateos, Hospital Universitario de Salamanca Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBERONC; Alberto Orfao, Servicio General de Citometría-NUCLEOS, Centro de Investigación del Cancer (IBMCC-USAL, CSIC), IBSAL and Department of Medicine, Universidad de Salamanca, CIBERONC, Salamanca; Lourdes Cordón and Javier De la Rubia, Hospital Universitario y Politécnico La Fe; Ana-Isabel Teruel, Hospital Clínico de Valencia, Valencia; Albert Oriol, Hospital Germans Trias i Pujol, Badalona; María-Asunción Echeveste, Hospital de Donostia, San Sebastian; Felipe de Arriba, Hospital Morales Meseguer, Murcia; Miguel T. Hernandez, Hospital Universitario de Canarias, Tenerife; Luis Palomera, Hospital Universitario Lozano Blesa, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.2517DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568033PMC
September 2017

Impact of induction treatment before autologous stem cell transplantation on long-term outcome in patients with newly diagnosed multiple myeloma.

Eur J Haematol 2017 Jun 24;98(6):569-576. Epub 2017 Mar 24.

ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12869DOI Listing
June 2017

Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.

J Clin Oncol 2016 11;34(32):3921-3930

A. Keith Stewart, Mayo Clinic, Scottsdale, AZ; Meletios A. Dimopoulos, Alexandra Hospital, Athens, Greece; Tamás Masszi, St. István and St. László Hospital, Semmelweis University, Budapest, Hungary; Ivan Špička, General University Hospital in Prague, Prague; Roman Hájek, University Hospital Brno and University of Ostrava, Brno, Czech Republic; Albert Oriol, Institut Català d'Oncologia, Institut Josep Carreras, Hospital Germans Trias i Pujol; Laura Rosiñol, Hospital Clínic de Barcelona, Barcelona; Jesus F. San-Miguel, Clinica Universidad de Navarra/El Centro de Investigacíon Médica Aplicada, Instituto de Investigacíon Sanitaria de Navarra, Pamplona, Spain; David S. Siegel, John Theurer Cancer Center at Hackensack University, Hackensack, NJ; Ruben Niesvizky, Weill Cornell Medical College, New York, NY; Andrzej J. Jakubowiak, University of Chicago Medicine, Chicago, IL; Heinz Ludwig, Wilhelminen Cancer Research Institute, Wilheminenspital, Vienna, Austria; Jacqui Buchanan, Xinqun Yang, Biao Xing, Naseem Zojwalla, and Margaret Tonda, Onyx Pharmaceuticals, South San Francisco, CA; Kim Cocks, KCStats Consultancy, Leeds, United Kingdom; Philippe Moreau, University of Nantes, Nantes, France; and Antonio Palumbo, University of Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.9648DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791840PMC
November 2016

Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma.

Br J Haematol 2016 Nov 19;175(3):448-456. Epub 2016 Jul 19.

Clinical and Translational Medicine, Clínica Universidad de Navarra - CIMA (Centro de Investigación Médica Aplicada) - IdiSNA (Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14263DOI Listing
November 2016

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 10;375(14):1319-1331

From the National and Kapodistrian University of Athens, Athens (M.A.D.); Institut Català d'Oncologia, Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona (A.O.), and Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona (J.S.-M.) - both in Spain; Karolinska Institute and the Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm (H.N.); Tom Baker Cancer Centre, University of Calgary, Calgary, AB (N.J.B.), and the Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto (D.R.) - both in Canada; Levine Cancer Institute-Carolinas HealthCare System, Charlotte, NC (S.Z.U.); the Department of Haematology, University College London Hospitals NHS Trust, London (N.R.); the Department of Lymphoma-Myeloma, University of Texas M.D. Anderson Cancer Center, Houston (R.Z.O.); the Department of Hematology and Stem Cell Transplantation, Poznan University of Medical Sciences, Poznan, Poland (M.K.); the Department of Hematology, Japanese Red Cross Medical Center, Tokyo (K.S.); Vejle Hospital and University of Southern Denmark, Vejle (T.P.), and Genmab, Copenhagen (S.L.) - both in Denmark; the Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea (S.-S.Y.); the Hematology Department, Hadassah-Hebrew University Medical Center, Jerusalem (D.B.Y.); Dana-Farber Cancer Institute, Harvard Medical School, Boston (P.G.R.); University Hospital Heidelberg and the German Cancer Research Center, Heidelberg, Germany (H.G.); Janssen Research and Development, Spring House, PA (N.Z.K., L.O., C.C., X.Q., M.G., T.A.); and the Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France (P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1607751DOI Listing
October 2016

Treatment of relapsed or refractory acute lymphoblastic leukemia in adult patients.

Authors:
Albert Oriol

Acta Haematol 2015 23;133(1):89-90. Epub 2014 Aug 23.

Clinical Hematology Service and Oncohematological Clinical Trial Unit, Institut Català d'Oncologia (ICO), and Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Hospital Germans Trias i Pujol, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000362778DOI Listing
February 2015

Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.

Eur J Haematol 2014 Dec 21;93(6):487-91. Epub 2014 Jun 21.

Clinical Haematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, José Carreras Research Institute, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12386DOI Listing
December 2014

[New drugs in the treatment of multiple myeloma].

Med Clin (Barc) 2014 Sep 15;143(6):268-74. Epub 2013 Dec 15.

Servicio de Hematología clínica y Unidad de investigación Clínica, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2013.10.012DOI Listing
September 2014

Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.

J Clin Oncol 2014 May 21;32(15):1595-604. Epub 2014 Apr 21.

Josep-Maria Ribera, Albert Oriol, Mireia Morgades, and Evarist Feliu, Institut Català d'Oncologia-Hospital Germans Trias i Pujol-Jose Carreras Research Institute; Salut Brunet, Hospital de Sant Pau; Jordi Esteve, Hospital Clínic; Pere Barba, Hospital Vall d'Hebron, Barcelona; Pau Montesinos, Hospital Universitario La Fe; Mar Tormo, Hospital Clínico, Valencia; Josep Sarrà, Institut Català d'Oncologia-Hospital Duran i Reynals, L'Hospitalet de Llobregat; José González-Campos, Hospital Universitario Virgen del Rocío, Sevilla; Pascual Fernández-Abellán, Hospital General, Alicante; Ramon Guàrdia, Institut Català d'Oncologia-Hospital Josep Trueta, Girona; María-Teresa Bernal, Hospital Central de Asturias, Oviedo; María-José Moreno, Hospital Virgen de la Victoria, Málaga; Arancha Bermúdez, Hospital Marqués de Valdecilla, Santander; Antonia Cladera, Hospital Son Llàtzer, Palma de Mallorca; Lourdes Escoda, Hospital Joan XXIII, Tarragona; Raimundo García-Boyero, Hospital General, Castellón; Eloy del Potro, Hospital Clínico San Carlos; Carlos Grande, Hospital Doce de Octubre, Madrid; Juan Bergua, Hospital San Pedro de Alcántara, Cáceres; María-Luz Amigo, Hospital Morales Meseguer, Murcia; María-José Rabuñal, Hospital Xeral, Santiago de Compostela; and Jesús-María Hernández-Rivas, Hospital Universitario-Instituto del Cáncer, Universidad de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.2425DOI Listing
May 2014

Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.

N Engl J Med 2013 Aug;369(5):438-47

Hospital Universitario de Salamanca, Instituto de Biología Molecular y Celular del Cáncer, Universidad de Salamanca-Consejo Superior de Investigaciones Científicas, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1300439DOI Listing
August 2013

Technology as an enabler of change.

Hosp Health Netw 2013 Jan;87(1):51-61

Henry County Health Center, Mount Pleasant, Iowa, USA.

View Article

Download full-text PDF

Source
January 2013

Multiple myeloma with extramedullary disease.

Authors:
Albert Oriol

Adv Ther 2011 Nov 11;28 Suppl 7:1-6. Epub 2011 Nov 11.

Department of Hematology, Hospital Germans Trias i Pujol, Carretera de Canyet, s/n. 08916 Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-011-0079-0DOI Listing
November 2011

Extramedullary plasmacytomas in the context of multiple myeloma.

Adv Ther 2011 Nov 11;28 Suppl 7:7-13. Epub 2011 Nov 11.

Department of Hematology, Hospital Universitario de Princesa, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-011-0073-6DOI Listing
November 2011